Evaluation of the effect of RIPC (remote ischemic preconditioning) on migrane headache and Brain metabolites in MRS (magnetic resonance spectroscopy) and qEEG indices of migraine patients a pilot study

Rasht University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新: 2022年6月27日

试验速览

暂无简介。

•Patient have at least 5 headache attacks lasting 4–72 hours (without treatment or unsuccessful treatment)
•Age range from 18 to 50 years
•The onset of migraines before menopause
•The ability of patients to distinguish migraine headaches from other conditions
•The patient's ability to fill out questionnaire
•Both male and female gender
•Informed consent

•Underlying diseases, history of chronic diseases or kidney, liver, cardiovascular, renal, pulmonary diseases, any malignancy, autoimmunity, diabetes mellitus
•Convulsions
•Head and neck trauma
•Asthenic damage
•Mental disorders and major depression according to DSM4
•Botox injection in the last 6 months
•Pregnancy and lactation
•Non-migraine headaches such as tension headaches that occur more than 12 times a month and cervicogenic
•Drug and alcohol dependence during the 1 year prior to the study
•Migraine with aura
•History of off pump surgery
•Severe hypertension higher than 160/90 mm / hg

发起方

Rasht University of Medical Sciences